CoChat

Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds

Open access
de Oliveira, André S., Gazolla, Poliana A. R., Oliveira, Ana Flávia C. da S., Pereira, Wagner L., de S. Viol, Lívia C., Maia, Angélica F. da S., Santos, Edjon G., da Silva, Ítalo E. P., Mendes, Tiago A. de Oliveira, da Silva, Adalberto M., Dias, Roberto S., da Silva, Cynthia C., Polêto, Marcelo D., Teixeira, Róbson R., de Paula, Sergio O. · 2019 · PLOS ONE

The DOI matches its Crossref record; 68 of the 71 references it cites were found in a registry or an index.

Abstract

The West Nile Virus (WNV) NS2B-NS3 protease is an attractive target for the development of therapeutics against this arboviral pathogen. In the present investigation, the screening of a small library of fifty-eight synthetic compounds against the NS2-NB3 protease of WNV is described. The following groups of compounds were evaluated: 3-(2-aryl-2-oxoethyl)isobenzofuran-1(3H)-ones; eugenol derivatives bearing 1,2,3-triazolic functionalities; and indan-1,3-diones with 1,2,3-triazolic functionalities. The most promising of these was a eugenol derivative, namely 4-(3-(4-allyl-2-methoxyphenoxy)-propyl)-1-(2-bromobenzyl)-1H-1,2,3-triazole (35), which inhibited the protease with IC50 of 6.86 μmol L-1. Enzyme kinetic assays showed that this derivative of eugenol presents competitive inhibition behaviour. Molecular docking calculations predicted a recognition pattern involving the residues His51 and Ser135, which are members of the catalytic triad of the WNV NS2B-NS3 protease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0223017

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 General structures of compounds evaluated as inhibitors of WNV NS2-NB3 protease. 3-(2-aryl-2-oxoethyl)isobenzofuran-1(3H)-ones (I); eugenol derivatives bearing 1,2,3-triazolic functionalities (II); indan-1,3-diones with 1,2,3-triazolic functionalities (III).
Fig 1 General structures of compounds evaluated as inhibitors of WNV NS2-NB3 protease. 3-(2-aryl-2-oxoethyl)isobenzofuran-1(3H)-ones (I); eugenol derivatives bearing 1,2,3-triazolic functionalities (II); indan-1,3-diones with 1,2,3-triazolic functionalities (III).CC BY · PubMed Central
Fig 2 Structures of compounds 1–18, 23–49, and 51–63.
Fig 2 Structures of compounds 1–18, 23–49, and 51–63.CC BY · PubMed Central
Fig 3 Preparation of alkylated derivatives of eugenol. i) NaOH, CH3OH, 40°C; acetonitrile, r.t; ii) NaOH, CH3OH, 40 oC; acetonitrile, 70 oC.
Fig 3 Preparation of alkylated derivatives of eugenol. i) NaOH, CH3OH, 40°C; acetonitrile, r.t; ii) NaOH, CH3OH, 40 oC; acetonitrile, 70 oC.CC BY · PubMed Central
Fig 4 Preparation of eugenol derivatives 23–49. iii) sodium ascorbate (40 mol%), CuSO4·5H2O (20 mol%), EtOH/H2O (1:1 v/v).
Fig 4 Preparation of eugenol derivatives 23–49. iii) sodium ascorbate (40 mol%), CuSO4·5H2O (20 mol%), EtOH/H2O (1:1 v/v).CC BY · PubMed Central
Fig 5 Synthesis of compounds 51–63. iv) aqueous KOH, then propargyl bromide, 40 oC, 24h; v) sodium ascorbate (40 mol%), CuSO4·5H2O (20 mol%), CH2Cl2/H2O (1:1 v/v), 2h.
Fig 5 Synthesis of compounds 51–63. iv) aqueous KOH, then propargyl bromide, 40 oC, 24h; v) sodium ascorbate (40 mol%), CuSO4·5H2O (20 mol%), CH2Cl2/H2O (1:1 v/v), 2h.CC BY · PubMed Central
Fig 6 Inhibitory activity screening for WNV protease. Fifty-eight compounds were evaluated at the concentration of 16 μmol L-1 against the WNV NS2-NB3 protease. The assays were conducted in triplicate during three isolated experiments (p value < 0.0001).
Fig 6 Inhibitory activity screening for WNV protease. Fifty-eight compounds were evaluated at the concentration of 16 μmol L-1 against the WNV NS2-NB3 protease. The assays were conducted in triplicate during three isolated experiments (p value < 0.0001).CC BY · PubMed Central
Fig 7 Enzymatic inhibitory profile of compound 35.
Fig 7 Enzymatic inhibitory profile of compound 35.CC BY · PubMed Central
Fig 8 Enzymatic kinetics of WNV NS2-NB3 protease in the presence of compound 35. In A, the Michaelis-Menten plot is shown. In B, the Lineweaver-Burk plot is presented.
Fig 8 Enzymatic kinetics of WNV NS2-NB3 protease in the presence of compound 35. In A, the Michaelis-Menten plot is shown. In B, the Lineweaver-Burk plot is presented.CC BY · PubMed Central
Fig 9 Dose-response profile of compound 35 on Vero cells.
Fig 9 Dose-response profile of compound 35 on Vero cells.CC BY · PubMed Central
Fig 10 WNV protease docking with compound 35 and 36. The entire protease is shown in lilac, highlighting residues Ser135 (dark blue), His51 (orange), and Asp75 (green). A. In white is compound 35. B. In gray is compound 36. Hydrogen bonds are shown in yellow, halogen bonds are shown in red, T-shape π-π interactions are shown in cyan and cation-π interactions are shown in pink.
Fig 10 WNV protease docking with compound 35 and 36. The entire protease is shown in lilac, highlighting residues Ser135 (dark blue), His51 (orange), and Asp75 (green). A. In white is compound 35. B. In gray is compound 36. Hydrogen bonds are shown in yellow, halogen bonds are shown in red, T-shape π-π interactions are shown in cyan and cation-π interactions are shown in pink.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 2

  1. JAB-F Cardozo, 2005, 3-Buthyl-isobenzofuranone: a compound isolated from Apium graveolens with anticonvulsant activity., Rev Colomb Ciencias Quim Farm, 34, 69
  2. J Mahadlek, 2010, Zinc Oxide Gels for periodontitis treatment, J Metal Mater Mineral, 20, 159

Cited by

See all 29

Metadata

Authors
de Oliveira, A. S., Gazolla, P. A. R., Oliveira, A. F. C. D. S., Pereira, W. L., de S. Viol, L. C., Maia, A. F. D. S., Santos, E. G., da Silva, Í. E. P., Mendes, T. A. D. O., da Silva, A. M., Dias, R. S., da Silva, C. C., Polêto, M. D., Teixeira, R. R., & de Paula, S. O.
Affiliations
  • Instituto Federal de Educação Ciência e Tecnologia do Norte de Minas Gerais (BR)
  • Universidade Federal de Viçosa (BR)
Corresponding author
Teixeira, Róbson R.
Venue
PLOS ONE
Published
2019-09-26
Volume
14
Issue
9
Pages
e0223017
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2976587599
Cited by
28
References
71
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 3 · 2021: 4 · 2020: 2
FWCI
2.07
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
  • Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
Keywords
West Nile virus, NS2B-NS3 protease, protease inhibitors, eugenol derivatives, 1,2,3-triazoles, indan-1,3-dione, competitive inhibition, catalytic triad, antiviral drug discovery
MeSH terms
Antiviral Agents, Eugenol, Histidine, Indans, Endopeptidases, Protease Inhibitors, Serine, Structure-Activity Relationship, West Nile virus, Viral Nonstructural Proteins, Inhibitory Concentration 50, Catalytic Domain, Drug Discovery, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds. https://app.cochat.ai/papers/10.1371/journal.pone.0223017
The paper
de Oliveira, A. S., Gazolla, P. A. R., Oliveira, A. F. C. D. S., Pereira, W. L., de S. Viol, L. C., Maia, A. F. D. S., Santos, E. G., da Silva, Í. E. P., Mendes, T. A. D. O., da Silva, A. M., Dias, R. S., da Silva, C. C., Polêto, M. D., Teixeira, R. R., & de Paula, S. O. (2019). Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds. PLOS ONE. https://doi.org/10.1371/journal.pone.0223017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.